Last reviewed · How we verify
Iron protein succinylate oral solution
Iron protein succinylate provides bioavailable iron in a protein-chelated form to treat iron deficiency by replenishing iron stores.
Iron protein succinylate provides bioavailable iron in a protein-chelated form to treat iron deficiency by replenishing iron stores. Used for Iron deficiency anemia.
At a glance
| Generic name | Iron protein succinylate oral solution |
|---|---|
| Sponsor | Lee's Pharmaceutical Limited |
| Drug class | Iron supplement |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Mechanism of action
This oral solution delivers iron bound to a protein-succinylate complex, which enhances absorption and reduces gastrointestinal irritation compared to simple iron salts. The iron is released and absorbed in the intestine to replenish hemoglobin and iron stores in patients with iron deficiency anemia.
Approved indications
- Iron deficiency anemia
Common side effects
- Gastrointestinal upset
- Constipation
- Nausea
- Abdominal discomfort
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: